Transforming growth factor-β and p27 expression in pituitary cells

Endocrinology

Volumn 137, Issue 7, 1996, Pages 3051-3060

  Qian, Xiang ^a   Jin, Long ^a   Grande, Joseph P ^a   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; FEMALE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0029894515     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.7.8770931     Document Type: Article

References (30)

1. 3 cells. Mol Endocrinol 5:1716-1722
2. Mueller SG, Kudlow JE 1991 Transforming growth factor-beta (TGF beta) inhibits TGF alpha expression in bovine anterior pituitary-derived cells. Mol Endocrinol 5:1439-1446
3. Albaladejo V, Fei ZL, Nicolas B, Joly-Pharaboz MO, Avallet O, Vigier M, Andre J 1992 Possible involvement of transforming growth factor-beta in the inhibition of rat pituitary tumor growth by estradiol. J Steroid Biochem Mol Biol 41:125-134
4. 4 pituitary cell proliferation. Endocrinology 128:1981-1990
5. Sarkar DK, Kim KH, Minami S 1992 Transforming growth factor-beta1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6:1825-1833
6. Burns G, Sarkar DK 1993 Transforming growth factor beta 1-like immunoreactivity in the pituitary gland of the rat: effect of estrogen. Endocrinology 133;1444-1449
7. Qian X, Jin L, Lloyd RV 1996 Expression and regulation of transforming growth factor β1 in cultured normal and neoplastic rat pituitary cells. Endocr Pathol 7:77-90
8. Massague J, Polyak K 1995 Mammalian antiproliferative signals and their targets. Curr Opin Gen Dev 5:91-96
9. Hunter T, Pines J 1994 Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582
10. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66
11. kip1, a cyclin-cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8:9-22
12. Toyoshima H, Hunter T 1994 p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74
13. kip1 in C3H10T 1/2 mouse fibroblasts. Cancer Res 55:1413-1416
14. Thiny MT, Antczak C, Fields K, Jin L, Lloyd RV 1994 Effects of estrogen and dexamethasone on a transgenic pituitary cell line. Regulation of hormone and chromogranin/secretogranin expression. Lab Invest 70:899-906
15. Lloyd RV, Coleman K, Fields K, Nath V 1987 Analysis of prolactin and growth hormone production in hyperplastic neoplastic rat pituitary tissue by the hemolytic plaque assay. Cancer Res 47:1086-1092
16. Chomczynski P 1993 A reagent for the single step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples. Biotechnique 15:532-537
17. Laemmli Uk 1970 Cleavage of structural protein during the assembly of the head of bacteriaphage T4. Nature 227:680-685
18. Lloyd RV, Schmidt K, Coleman K, Wilson BS 1986 Prolactin and growth hormone synthesis and thymidine incorporation in dissociated rat pituitary tumor cells. Proc Soc Exp Biol Med 181:18-23
19. Panoskaltsis-Mortari A, Bucy RP 1995 In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. BioTechniques 18:300-307
20. Wang AM, Doyle MV, Mark DF 1989 Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86:9717-9721
21. Jin L, Qian X, Lloyd RV 1995 Comparison of mRNA expression detected by in situ PCR and in situ hybridization in endocrine cells. Cell Vision 2:314-321
22. Lloyd RV, Jin L 1995 In situ hybridization analysis of chromogranin A and B mRNAs in neuroendocrine tumor with digoxigenin-labeled oligonucleotide probe cocktails. Diag Mol Pathol 4:143-151
23. Windle JJ, Weiner RI, Mellon PL 1990 Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 4:597-603
24. Pagano M, Tam SW, Theodoras Am Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M 1995 Role of ubiquitin-proteasome pathway in regulatory abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685
25. 3) rat pituitary cells. Cancer Res 49: 1247-1253
26. Kip1 in human malignancies. Cancer Res 55:2266-2269
27. Amara JF, Dannies PS 1983 17 beta estradiol has a biphasic effect on GH cell growth. Endocrinology 112:1141-1143
28. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK 1995 Reduction in the expression and action of transforming growth factor β1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Res 55:4892-4898
29. Piechaczyk M, Blanchard JM, Marty L, Dani C, Panabienes F, El Sabrouty S, Fort P, Jeanteur P 1984 Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissue. Nucleic Acids Res 12:6951-6963
30. Qian SW, Kondaiah P, Roberts AB, Sporn MB 1990 cDNA cloning by PCR of rat transforming growth factor-beta 1. Nucleic Acids Res 18:3059